Boundless Bio Launches With $46m And Novel Oncology Focus On Extrachromosomal DNA

 
• By Mandy Jackson
  
DNA strand and Cancer Cell Oncology Research Concept 3D rendering - Illustration
Boundless Bio is focused on extrachromosomal DNA as a cause of rapid tumor growth. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business